Aligos Therapeutics Inc

NASDAQ:ALGS   3:59:07 PM EDT
22.49
+1.30 (+6.14%)
Earnings Announcements

Aligos Therapeutics Posts Qtrly Loss Per Share $1.09

Published: 03/23/2021 21:12 GMT
Aligos Therapeutics Inc (ALGS) - Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights.
Qtrly Loss per Share $1.09.
Q4 Earnings per Share View $-0.83 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Investments Totaled $243.5 Million on December 31, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.80

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.87

More details on our Analysts Page.